Antonio DiGiandomenico, Ph.D.
Affiliations: | 2006 | University of Virginia, Charlottesville, VA |
Area:
Microbiology Biology, ImmunologyGoogle:
"Antonio DiGiandomenico"Parents
Sign in to add mentor| Joanna B. Goldberg | grad student | 2006 | UVA | |
| (Protection from Pseudomonas aeruginosa pneumonia after vaccination with recombinant live attenuated Salmonella: Correlates of protective immunity in the respiratory tract.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moustafa DA, DiGiandomenico A, Raghuram V, et al. (2023) Efficacy of a serogroup O9 vaccine. Infection and Immunity. e0024723 |
| Moustafa DA, DiGiandomenico A, Raghuram V, et al. (2023) Efficacy of a Serogroup O9 Vaccine. Biorxiv : the Preprint Server For Biology |
| Shaikh MOF, Schaefers MM, Merakou C, et al. (2022) Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice. Infection and Immunity. e0020322 |
| Kugadas A, Geddes-McAlister J, Guy E, et al. (2019) Frontline Science: Employing enzymatic treatment options for management of ocular biofilm-based infections. Journal of Leukocyte Biology |
| Chen B, Vousden KA, Naiman B, et al. (2018) Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses. Annals of the Rheumatic Diseases |
| Thompson JM, Miller RJ, Ashbaugh AG, et al. (2018) Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets. Jci Insight. 3 |
| Jones-Nelson O, Hilliard JJ, DiGiandomenico A, et al. (2018) The Neutrophilic Response to Pseudomonas Damages the Airway Barrier Promoting Infection by K. pneumoniae. American Journal of Respiratory Cell and Molecular Biology |
| Ali SO, Yu XQ, Robbie GJ, et al. (2018) A Phase 1 Study of MEDI3902, an Investigational Anti-Pseudomonas aeruginosa PcrV and Psl Bispecific Human Monoclonal Antibody, in Healthy Adults. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases |
| Tabor DE, Oganesyan V, Keller AE, et al. (2018) Pseudomonas aeruginosa PcrV and Psl, the molecular targets of bispecific antibody MEDI3902, are conserved among diverse global clinical isolates. The Journal of Infectious Diseases |
| Borrok MJ, DiGiandomenico A, Beyaz N, et al. (2018) Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies. Jci Insight. 3 |